Calumet (CLMT) director receives 3,796 vested RSUs (06/24/2025)
Amy M. Schumacher, a director of Calumet, Inc. (CLMT), reported receipt of 3,796 restricted stock units on 06/24/2025.
Rhea-AI Filing Summary
Amy M. Schumacher, a director of Calumet, Inc. (CLMT), reported receipt of 3,796 restricted stock units on 06/24/2025. The RSUs are described as the economic equivalent of one share each and are 100% vested. Each RSU is payable either in one share of Calumet common stock or the cash value thereof, and the reported acquisition price is $0 (reflecting issuance/settlement of RSUs rather than a cash purchase). The report lists 246,040 shares as the amount of securities beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025.
Positive
- 3,796 Restricted Stock Units were acquired, and they are 100% vested
- RSUs are payable in one share each or cash, providing flexibility at settlement
- Reporting person identified as Amy M. Schumacher, a director, improving disclosure clarity
Negative
- None.
Insights
Director received 3,796 vested RSUs on 06/24/2025.
The filing shows 3,796 Restricted Stock Units were acquired and are 100% vested, meaning the reporting person has an immediate economic interest in those units. The RSUs convert into one share each or cash at settlement, and the transaction price is reported as $0, which is typical for compensation-related awards that vest rather than open-market purchases.
The report also discloses 246,040 shares beneficially owned following the transaction, establishing the director's total reported stake as recorded on this Form 4.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 3,796 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.01 per share | 3,796 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
- F2. Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amy M. Schumacher report on Form 4 for CLMT?
What is the settlement option for the RSUs reported on CLMT Form 4?
When was the Form 4 signed and who signed it?
AI-generated analysis. How Rhea-AI works. Not financial advice.